Role of "-Adrenoreceptors In The Regulation of Fore-Stomach Motility in the Goat

Similar documents
Dexmedetomidine. Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai. History

ANTAGONISM OF XYLAZINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE IMMOBILIZATION IN GUINEAFOWL (NUMIDA MELEAGRIS) BY YOHIMBINE HYDROCHLORIDE

SUMMARY OF PRODUCT CHARACTERISTICS

PDF of Trial CTRI Website URL -

Reversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole

SUMMARY OF PRODUCT CHARACTERISTICS

USE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES

SUMMARY OF PRODUCT CHARACTERISTICS

DISSOCIATIVE ANESTHESIA

SUMMARY OF PRODUCT CHARACTERISTICS

PHAMACOLOGY 2 nd EXAM QUESTIONS 2012/2013

Day 90 Labelling, PL LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

single intravenous and oral doses and after 14 repeated oral

SUMMARY OF PRODUCT CHARACTERISTICS. Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)

Summary of Product Characteristics

SOME OBSERVATIONS ON PECKING IN PIGEONS

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

DOI /yydb medetomidine a review of clinical applications J. Curr Opin Anaesthesiol

Premedication with alpha-2 agonists procedures for monitoring anaesthetic

! The best anaesthesia is the one you have experience with!

The UCD community has made this article openly available. Please share how this access benefits you. Your story matters!

Standing sedation with medetomidine and butorphanol in captive African elephants (Loxodonta africana)

SINGLE ANNUAL IMPLANT

ABSTRACT. The effect of exogenous oxytocin injected on different days of estrus cycle and pregnancy on uterine PGF 2a

DOG CHEMICAL & NON-CHEMICAL CAPTURE AND HANDLING Maximizing Success and Minimizing the Fight For Animal Control Officers

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and

These are the topics typically covered in GWR courses All labs with live animals have been approved by several Animal Care and Use Committees.

JMSCR Vol 05 Issue 03 Page March 2017

Luteolysis and Pregnancy Outcomes in Dairy Cows after Treatment with Estrumate or Lutalyse

Candidate Name: PRACTICAL Exercise Medications & Injections

THE UNIVERSITY OF NEW ENGLAND ANIMAL ETHICS COMMITTEE (AEC)

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

Sedative and Analgesic Effects Of Detomidine Or Detomidine and Butorphanol In The Donkey

Xylavet 20 mg/ml, solution for injection for cattle, horses, dogs and cats (AT, DE)

Xylasol 100 mg/ml, solution for injection for cattle and horses (BE, ES, FR, HU, IE, IT, NL and UK)

Feline blood transfusions: preliminary considerations

(Received 5 December 1966)

Vet 4/5 Practice Exam Review

9.0 ANTHELMINTIC STUDIES

Cepesedan 10 mg/ml, Solution for Injection for Horses and Cattle

Effects of Late-Summer Protein Supplementation and Deworming on Performance of Beef Calves Grazing Native Range

Summary and Conclusion

Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.

Part 1 : General multiple-choice questions

DOSE ROUTE FREQUENCYREFERENCENOTES

Plasma and salivary cortisol levels in transportationstressed

Pain Management in Racing Greyhounds

Which is More Effective in Altering the Intra-Gastric ph in Dogs, Omeprazole or Ranitidine?

UNTHSC. Institutional Animal Care and Use Committee. Title: Euthanasia Guidelines. Document #: 006 Version #: 02

For the treatment and prevention of infections caused by:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

EXCEDE Sterile Suspension

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

Is Atipamezole better than Yohimbine for reversal of Xylazine in male C57BL/6 mice anesthetized with Ketamine/Xylazine?

DEPARTMENT OF CLINICAL STUDIES POLICY ON FREQUENCY OF USE OF TEACHING AND DONATED ANIMALS

Oral sedation of horses

European Public MRL assessment report (EPMAR)

Preanesthesia in dogs Dog Weight. Sedation/analgesia in dogs Dog Weight. Sedation/analgesia and preanesthesia in cats

Amitraz poisoning: A case report of an unusual pesticide poisoning in Sri Lanka and literature review

UPDATE ON OVULATION-CONTROL PROGRAMS FOR ARTIFICIAL INSEMINATION OF LACTATING DAIRY COWS. J. S. Stevenson

Dexmedetomidine and its Injectable Anesthetic-Pain Management Combinations

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

PHYSICIAN ORDERS. Page 1 of 6. Provider Initial: Esophagectomy Preoperative [ ] Height Weight Allergies

BLOOD VESSELS BY. (REcEIvED june 9, 1954) membrane there was a significant fall in true. to support the view that the hypersensitivity of the

COMPARISON OF EFFECTS OF XYLAZINE, DETOMIDINE AND MEDETOMIDINE ON HEART RATE, RESPIRATORY RATE AND BLOOD GLUCOSE LEVEL IN SHEEP

GUIDELINES FOR ANESTHESIA AND FORMULARIES

December 2010, Issue 26. Season's Greetings from all of us at AMVS to all of you! May your holidays be bright and your new year abundant.

PHYSIOLOGICAL RESPONSE OF GRAY WOLVES TO BUTORPHANOL-XYLAZINE IMMOBILIZATION AND ANTAGONISM BY NALOXONE AND YOHIMBINE

POST-OPERATIVE ANALGESIA AND FORMULARIES

ECG CHANGES IN DOGS SEDATED WITH DEXMEDETOMIDINE AND MIDAZOLAM- DEXMEDETOMIDINE COMBINATION

SOUTH AFRICAN VETERINARY COUNCIL REGISTRATION EXAMINATION LIST OF PROCEDURES: PRACTICAL AND/OR ORAL/PRACTICAL EXAMINATION VETERINARIANS

PAIN Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic knee surgery

ASMIC 2016 DEXMEDETOMIDINE IN THE INTENSIVE CARE UNIT DR KHOO TIEN MENG

Variation in Duration of Estrus. Dr. Michael Smith, Un. of Missouri August 17, Overview. Ovarian Structures Graffian follicle.

- Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.

HISTAMINE has long been known to

EMEDOG 1mg/ml Solution for injection for dogs. Part I ADMINISTRATIVE DATA AND SUMMARY OF THE DOSSIER

Just where it s needed.

Clinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 / 2007

Clinical Examination: Review

EUTHANASIA OF DOGS (Photos courtesy of KwaZulu-Natal Rabies Project and World Animal Protection)

Electronic and visual identification for sheep and goats in Brazil

Summary of Product Characteristics

Susan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA

important SAfEty information angel.com

Residues of Cymelarsan R in camels (Camelus dromedaries) and Nubian goats infected with T.evansi in Sudan

New treatments for psoriasis: which biologic is best? Nelson A A, Pearce D J, Fleischer A B, Balkrishnan R, Feldman S R

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Northwest A&F University, College of Veterinary Medicine, Yangling, China 3

MOXIDECTIN SPOT-ON SOLUTION FOR KITTENS AND SMALL CATS. 280 mg/ml FLURALANER 14 mg/ml MOXIDECTIN Also contains: 339 mg/ml DIMETHYLACETAMIDE (solvent)

Economic Significance of Fasciola Hepatica Infestation of Beef Cattle a Definition Study based on Field Trial and Grazier Questionnaire

Study of the Side effects profile of different antihypertensive drugs among the Hypertensive patient

Anaesthetic effects of tiletamine-zolazepam-xylazine-tramadol combination in cats undergoing surgical sterilization

Original Article Dose-dependent effects of dexmedetomidine during one-lung ventilation in patients undergoing lobectomy

Transcription:

Pakistan Journal of Biological Sciences 3 (1): 65-68, 2000 Copyright by the Capricorn Publication 2000 Role of "-Adrenoreceptors In The Regulation of Fore-Stomach Motility in the Goat T.E.A. Osman and K.A. AI-Busadah Department of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine and Animal Resources, King Faisal University, P.O. Box 1757, Al-Ahsa 31982, Saudi Arabia Abstract: The investigation of the effects of intravenous (i.v.) infusion of "2-adrenoreceptor agonists and antagonists on reticuloruminal motility was carried out in conscious goats. The i.v. administration of the "1-agonist phenylephrine (4 µg kgg 1 ming 1 for 15 min) or the "2-agonist naphazoline (2.5 µg kgg 1 ming 1 for 15 min) reduced both frequency and amplitude of reticulum and rumen dorsal sac contractions. Pretreatment of animals with the "1-antagonist prazosin (20 µg kgg 1 ming 1 for 30 min) prevented the inhibitory effects of phenylephrine on reticuloruminal motility. The effects of naphazoline were prevented by yohimbine, an "2-antagonist at 20 µg kgg 1 ming 1 for 30 min. Yohimbine, given alone or followed by naphazoline, abolished secondary ruminal dorsal sac contractions. It is concluded that both "12 and "2-adrenoreceptors are involved in the regulation of reticuloruminal motility in the goat. At the dosage of drugs used al and "2-adrenoreceptors appear to play an inhibitory effect on reticuloruminal motility in the goat. Key words: Adrenoreceptors, regulation, fore-stomach motility, goat Introduction The cyclical contractions of the reticulum arid rumen are dependent on vago-vagal reflexes coordinated in the medulla oblongata. Published reports have shown that the adrenergic receptors, located both centrally and it the reticuloruminal wall are involved in the regulation of forestomach motility in ruminants (Ruckebusch, 1983). Many reports indicated that the injection of "-adrenoreceptor antagonists had no significant effects on reticuloruminal motility (Toutain et al., 1982; Nicholson et al., 1988; Nicholson and Osman, 1992). However, at higher doses Toutain et al. (1982) noted that phentolamine (0.2 mg kgg 1 ) and prazosin (0.4 mg kgg 1 ) inhibited reticular motility in sheep and Ruckebusch and Toutain (1984) found that reticular motility of cattle was inhibited by tolazoline at 2 mg kgg 1. Brikas (1989) observed that i.v. infusion of yohimbine (20 µg kgg 1 ming 1 for 30 min), either alone or followed by naphazoline, abolished secondary ruminal phasic myoelectrical grouped discharges, in sheep. The injection of "-adrenoreceptor agonists produced a variety of reticuloruminal responses, possibly because of differences in agonists used, their dosage and site of injection. Titchen and Newhook (1968) found that phentolamine and tolazoline blocked the inhibitory effects of adrenaline and noradrenaline on ruminal motility in sheep and goats. Van Miert (1969) found that "-and-$adrenoreceptor agonistis phenylephrine and isoprenaline, respectively, produced a reduction in the amplitude and rate of ruminal contractions in the goat. Nicholson and Osman (1992) reported that idazoxan, an "2-antagonist, abolished the inhibitory effects of clonidine on forestomach motility and food intake in sheep. Brikas (1989) found that the administration of the "2-agonist naphazoline stopped the reticular phasic myoelectrical grouped discharges (MPGD) and greatly decreased the frequency of ruminal PMGD in sheep. This effect was blocked when the animals were pretreated with the "2-blocker yohirnbine. The administration of the "1-agonist phenylephrine significantly increased the frequency of reticuloruminal PMGD and provoked rumination, an effect blocked by pretreatment of animals with the "-antagonist prazosin (Brikas, 1989). In contrast, Campion and Leek (1995) found that the infection of the "1-agonist phenylephrine was ineffectual in evoking rumination and resulted in a reduced reticular motility. The present study was undertaken to investigate the role of "-adrenoreceptors on reticuloruminal motility in the goat by i.v. infusion of "1-and-"2-adrenorceptor agonists and antagonists. Materials and Methods Animals: Four male Nubian goats, 1.5-2.0 years old and weighing 10.0-15.0 kg, were used in the present experiments. Each goat had a long-established rumen cannula by the two-stage method of Jarrett (1948). To facilitate intravenous infusions they were fitted with jugular vein catheters well in advance of all experimental days. These catheters were flushed regularly with sterile saline and filled with heparinized saline. Training and Feeding Schedule: The goats were housed in individual pens and moved to floor level stands, in which they could not turn round, in the same room as for the experiments. They were rigorously trained to walk into the stands and remain standing there with minimal restraint. A string was passed and tied under the abdomen to prevent the goad from lying dow, but not tight enough to suspend it. The goats were fed on dried alfa alfa and water was available ad libitum. Recording: Reticulum and rumen dorsal sac contractions were recorded by placing small (40 mm 3 ) air-filled balloons in these two compartments. These were connected with pressure transducers linked to a 4-channel recorder (Rikadenki, WK 450, Germany). In these animals rumination activity was recognized as triphasic contractions of the reticulum, whereas non-ruminating (resting) motility was that with a biphasic pattern. 65

Drugs: In these experiments the following drugs were used: i) L-phenylephrine HCL (Sigma Chem. Co., USA) and naphazoline (HCL (Sigma Chem. Co. USA) as "1-and "2-adrenoeceptor agonists, respectively and ii) prazosin HCL (Pfizer Limited, Sandwich, England) and yohimbine HCL (Sigma Chem. Co. USA) as "1-and-"2-adrenoreceptor antagonists. respectively. Shortly before use, the given doses of the drugs were dissolved in no more than 20 ml of sterile normal saline. Protocol: The recording of reticulorumial contractions of each goat was performed daily. At 07.00 hours, the animal was placed in a loose box, the balloons were introduced into the reticulum and rumen dorsal sac and connected to the recorder with a recording speed of 25 mm ming 1. Each of the four goats were subjected to each experiment of the following series. a. The goat was given through the jugular vein catheter (i.v.) phenylephrine (4 µg kgg 1 ming 1 for 15 min) and naphazoline (2.5 µg kgg 1 ming 1 for 15 min) b. The goat received i.v. for 30 min prazosin (20 µg kgg 1 ming 1 ) and yohimbine (20 µg kgg 1 ming 1 ) c. During these experiments, the animals received i.e phenylephrine or naphazoline, preceded by the i.v. administration or prazsoin or yohimbine, respectively. At the beginning of each experiment, one hour of control recording preceded the drug administration, then recording was continued for 1-2 hours after the infusion was stopped. Statistical analysis: Reticulo-ruminal motility was determined by counting the number of complexes occurring in 15 or 30 min periods before, during and after the administration of drugs. The results were expressed as mean ± SE. Differences were evaluated using the paired Student's Hest and significance was accepted where p<0.05. Results Effect of "-adrenoreceptor agonists: The i.v. infusion of phenylephrine at a dose rate of 4 µg kgg 1 ming 1 for 15 ming 1 tended to reduce both reticulum and rumen dorsal sac contractions. This reduction was evident during the infusion period and it was statistically significant (p<0.05) at 30 min for the reticulum and at 30 and 60 min post-infusion for the rumen dorsal sac (Table 1). The administration of naphazoline at a dose rat of 2.5 µg kgg 1 ming 1. for 15 min, caused a progressive inhibition of reticuloruminal motility (Fig. 1). The reduction of reticular motility was significantly different (p<0.05) from control during the infusion period and for up to 120 min after the infusion was stopped (Table 1). Concerning rumen dorsal sac contractions, they were reduced during the infusion and the reduction was significantly (p<0.05) different for up to 60 min after the infusion was stopped. Effects of "-adrenoreceptor antagonists: The administration of prazosin at a dose rate of 20 µg kgg 1 ming 1 for 30 min had no significant effect on reticulum and rumen dorsal sac contractions (Table 2). On the other hand, i.v. infusion of Fig. 1: The blocking effect of yohimbine on naphazolineinduced inhibition of reticulo-ruminal motility in a conscious goat. a) Naphazoline alone (2.5 µg kgg 1 ming 1 for 15 min) abolished reticulum and primary rumen dorsal sac con-tractiions, but had no effect on secondary contractions b) Yohimbine alone (20 µg kgg 1 ming 1 for 30 min) progress-ively abolished rumen secondary contractions and induced ruminatiion (arrow heads) c) Yohimbine infusion prior to naphazotine blicked the inhibitory effect of naphazoline on frestomach contract ions. = rumination; S = rumen secondary contractions yohimbine at a dose of rate of 20 µg kgg 1 ming 1 for 30 min significantly (p<0.05) increased reticulum contractions during the infusion period and at 30, 90 and 120 min after the infusion was stopped (Table 2). Yohimbine administration had no significant effect on dorsal rumen contractions. However, during the infusion of yohimbine there was a progressive inhibition of secondary rumen contractions, which were completely abolished 10-15 min after the beginning of yohimbine infusion (Fig. 1). The administration of yohimbine was always associated with rumination activity that lasted for 2 hours following the termination of infusion (Fig. 1). Blocking effects of "-adrenoreceptor antagonists: The reduction of the frequency of reticuloruminal contractions observed during and after the i.v. administration of phenylephrine (4 µg kgg 1 ming 1 for 15 min) was completely blocked when the goats were pretreated i.v. with prazosin at a dose rat of 20 µg kgg 1 ming 1 for 30 min (Table 3). The reduction of reticuloruminal motility caused by the i,v, infusion of naphazoline (2.5 µg kgg 1 ming 1 for 15 min) did not occur when the goats were pretreated with yohimbine at a dose rate of 20 µg kgg 1 ming 1 for 30 min (Fig. 1 and 66

Table 1: Mean ± S.E. reticulo-ruminal contractions after adrenoreceptor antagonists infusion in 30 min successive interval in goats (N = 4) Time (min) Phenylephrine 4 µg kgg 1 ming 1 Naphazoline 2.5 µg kgg 1 ming 1 for 15 min for 15 min ------------------------------------------------------------- ------------------------------------------------------------------ -30 13.0±0.7R 20.8±1.4 15.5±0.9 23.5±1.2-15 - 16.0±1.3R 24.8±2.3 15.5±0.5R 23.0±1.0 +15 13.3±1.5 18.5±2.1 7.8±1.0* 11.3±1.1 30 12.5±0.7 18.3±0.7 2.5±0.5* 7.0±0.9* 45 9.8±0.7* 14.5±0.9* 4.0±1.4* 7.5±1.7* 60 11.3±0.8 16.5±0.9 2.3±0.9* 5.8±0.8* 75 12.5±1.0 18.0±1.5* 3.3±0.8* 8.3±1.5* 90 11.8±0.5 16.8±0.6 6.3±1.5* 13.0±2.6 105 14.5±0.3 22.5±1.5 4.8±1.4* 10.8±2.4 120 12.0±0.5 18.5±1.1 6.5±1.1* 13.3±2.1 135 13.3±1.3 19.8±1.8 6.3±0.7* 14.0±1.1 * Significantly different from control (p<0.05); R = rumination Table 2: Mean±S.E. reticulo-ruminal contractions after adrenoreceptor antagonists infusionin 30 min successive interval in goats (N=4) Time (min) Prazosin 20 µg kgg 1 ming 1 for 15 min Yohimbine 20 µg kgg 1 ming 1 for 15 min ------------------------------------------------------------ ------------------------------------------------------------------- -30 31.5±1.5 48.5±1.7 37.5±0.8 53.5±0.8 +30 31.3±1.9 50.5±1.4 50.5±3.3R 55.3±3.0 60 30.5±1.3 54.0±1.4 54.0±3.0R 58.0±3.3 90 30.3±1.6 52.8±1.6 47.0±2.6R 54.5±2.8 120 30.8±0.5 48.3±2.5 48.0±1.6R 59.3±2.5 150 31.7±1.2 49.8±1.9 47.0±1.1R 56.0±1.2 *Significantly different from control (p<0.05); R = rumination Table 3: Mean±S.E. reticulo-ruminal contractions after adrenoreceptor antagonists infusion followed by adrenergic receptor agonists in 15 min interval in goats (N = 4) Time (min) Yohimbine 20 20 µg kgg 1 ming 1 for 30 min + Prazosin 20 20 µg kgg 1 ming 1 for 30 min + Naphazoline 25 20 µg kgg 1 ming 1 for 15 min phenylephrine 4 20 µg kgg 1 ming 1 for 15 min -------------------------------------------------------------- ------------------------------------------------------------------- -30-15 18.0±1.2R 24.7±1.6 15.3±1.1 22.7±1.2-15-0 16.0±1.2R 23.0±1.7 15.7±1.8R 22.3±1.1 *0-15 18.0 t 0.9R 20.3±0.5 16.3±0.9R 21.3±0.9 15-30 27.7±3.9R 27.7±3.9 16.0±0.9 23.0±0.9 0-15 23.0±1.7R 23.3±1.6 17.3±1.3 24.3±2.2 15-30 20.7±1.8 21.7±1.3 15.7±0.8 23.0±2.1 30-45 16.0±1.2 17.0±0.6 16.7±0.5R 23.3±1.9 45-60 16.0±0.9 17.3±0.2 15.7±0.7 19.3±1.1 60-75 15.0±0.6 16.0±0.3 14.3±0.5 18.7±0.9 75-90 16.7±0.7 18.7±0.9 16:3±0.2 20.7±1.3 90-105 15.7±0,9 17.3±0.4 14.7±0.7 19.7±0.9 105-120 14.7±0.5 16.7±0.7 15.0±1.5 20.0±0.9 120-135 15.3±0.4 17.3±0.4 12.0±0.9 17.7±1.1 *Significantly different from control (p<0.05); R = rumination 67

Table 3). In these cases, the inhibition of rumial secondary contractions induced by yohimbine infusion continued after the administration of naphazoline (Fig. 1). Also rumination activity was present during control period and during the infusion of yohimbine. However, the administration of naphazoline suppressed rumination activity (Table 3). Discussion The present work supports previous data in indicating that the adrenergic receptors are involved in the regulation of reticulo-ruminal motility (Ruckebusch, 1983). Phenylephrine, an "1-adrenergic agonist, decreased the frequency and amplitude of reticuloruminal contractions and failed to evoke rumination. This agrees with observations by Van Miert (1969) when phenylephrine was given intrajugularly and Campion and Leek (1995) with phenylephrine given into the coeliac artery. This contrasts with the findings of Brikas (1989) that the i.v. fusion of phenylephrine (2.5 µg kgg 1 ming 1 for 30 min or 4 µg kgg 1 ming 1 for 15 min) increased the frequency of reticuloruminal cyclical contractions and provoked rumination sheep. When the goats were intravenously pretreated with prazosin, a highly selective antagonist for the "1 -receptors (Hoffman, 1984) which did not in itself exert any excitatory or inhibitory influence on reticuloruminal activity, the effects of phenylephrine on reticuloruminal motility were completely blocked. The involvement of the "2-adrenoreceptors in the regulation of goat reticuloruminal motility was studied in the present work using the fairly selective "2-agonist naphazoline (Lees, 1981). Infusion of this drug caused a progressive inhibition of reticulo-ruminal motility which was significantly different from the control period. This confirms previous reports that intravenous injection of "2-agonists depressed the amplitude and/or frequency or reticulo rumination contractions (Toutain et al., 1982; Guard and Schwark, 1984; Ruckebusch and Toutain, 1984; Brikas et al., 1986; Brikas, 1989; Nicholson and Osman, 1992; Campion and Leek, 1995). The inhibitory effects of naphazoline did not occur when the goats were intravenously pretreated with yohimbine, a quite selective antagonist for the "2- adrenoreceptors. In the present study, yohimbine infused i.v. at a dose rate of 20 µg kgg 1 ming 1 or 15 min, either alone or followed by naphazoline, caused a progressive inhibition of secondary rumen contractions. These contractions were completely abolished 10-15 minutes after the beginning of yohimbine infusion. This agrees with observations by Brikas (1989) when yohimbine was infused into the jugular vein of sheep. In contrast, Guard and Schwark (1984) reported no change in the rate of rumen contractions when yohimbine was given as a bolus into the jugular vein of calves. The incidence of rumination observed during the present study associated with the i.v. infusion of yohimbine remains obscure. However, Nicholson and Belkhiri (1990) reported that rumination may be stimulated by a recording balloon in the reticulum of sheep. But since the same method was adopted for recording forestomach motility in the goats used in the present work, the stimulation of rumination activity by yohimbine needs further investigations. References Brikas, P., 1989. The adrenergic receptors in the control of reticulo-ruminal myoelectrical activity in sheep. J. Vet. Med. Ser. A, 36: 402-410. Brikas, P., C. Tsiamitas and R.S. Wyburn, 1986. On the effect of xylazine on forestomach motility in sheep. J. Vet. Med. Ser. A, 33: 174-179. Campion, D.P. and B.F. Leek, 1995. The effects of intracoeliac injections of alpha-adrenergic agonists and veratridine on reticuloruminal motility and the evocation of rumination in sheep. J. Vet. Med. Ser. A, 42: 443-451. Guard, C.L. and W.S. Schwark, 1984. Influence of yohimbine on xylazine-induced depression of central nervous, gastrointestinal and cardiovascular function in the calf. Cornell Vet., 74: 312-321. Hoffman, B.B., 1984. Adrenergic Receptor-Activating Drugs. In: Basic and Clinical Pharmacology, Katzung, B.G. (Ed.). 2nd Edn., Lange Medical Publications, Los Altos, CA., USA., pp: 86-106. Jarrett, I.G., 1948. The production of rumen and abomasal fistulae in sheep. J. Counc. Scient. Ind. Res., 21: 311-315. Lees, G.M., 1981. A hitch-hiker's guide to the galaxy of adrenoceptors. Br. Med. J., 283: 173-178. Nicholson, T. and M. Belkhiri, 1990. Rumination may be stimulated by a recording balloon in the reticulum of the sheep. J. Vet. Med. Ser. A, 37: 558-560. Nicholson, T. and T.E.A. Osman, 1992. Inhibition of food intake and reticulo-rumen motility of sheep by the alpha-2 adrenoreceptor agonist clonidine. J. Vet. Med. Ser. A, 39: 301-312. Nicholson, T., T.E.A. Osman and M. Belkhiri, 1988. Inhibition of rumination in sheep by "-adrenoreceptor antagonists. J. Vet. Pharmacol. Therapeut., 11: 276-282. Ruckebusch, Y. and P.L. Toutain, 1984. Specific antagonism of xylazine effects on reticulo-rumen motor function in cattle. Vet. Med. Rev., 84: 3-12. Ruckebusch, Y., 1983. Pharmacology of reticulo-ruminal motor function. J. Vet. Pharmacol. Therapeut., 6: 245-272. Titchen, D.A. and J.C. Newhook, 1968. Adrenergic effector mechanisms in the stomach of the sheep. J. Pharm. Pharmacol., 20: 947-948. Toutain, P.L., M.R. Zingoni and Y. Ruckebusch, 1982. Assessment of alpha-2 adrenergic antagonists on the central nervous system using reticular contraction in sheep as a model. J. Pharmacol. Exp. Therapeut., 223: 215-218. Van Miert, A.S.J.P.A.M., 1969. The effects of "- and $-sympathicomimetics on rumen motility and heart rate frequency in conscious goats. J. Pharm. Pharmacol., 21: 697-699. 68